Nahdi Medical Company (TADAWUL:4164)

Nahdi Medical Company Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	14,846	15,288	17,810	21,736	-	-
Market Cap Growth	-14.16%	-14.16%	-18.06%	-	-	-
Enterprise Value	15,419	16,025	17,991	22,301	-	-
Last Close Price	114.20	114.59	128.31	151.45	-	-
PE Ratio	18.09	18.63	19.95	24.48	-	-
Forward PE	16.83	17.51	20.42	23.26	-	-
PS Ratio	1.57	1.62	2.04	2.52	-	-
PB Ratio	5.74	5.91	7.23	9.69	-	-
P/TBV Ratio	5.90	6.07	7.39	9.90	-	-
P/FCF Ratio	12.89	13.27	18.51	15.33	-	-
P/OCF Ratio	9.95	10.25	13.53	13.03	-	-
PEG Ratio	-	6.95	6.59	3.46	-	-
EV/Sales Ratio	1.63	1.70	2.07	2.59	-	-
EV/EBITDA Ratio	9.96	14.18	15.24	18.71	-	-
EV/EBIT Ratio	17.69	18.38	18.73	22.31	-	-
EV/FCF Ratio	13.39	13.91	18.70	15.73	-	-
Debt / Equity Ratio	0.59	0.59	0.48	0.52	0.85	0.59
Debt / EBITDA Ratio	0.99	0.99	0.76	0.74	0.93	0.85
Debt / FCF Ratio	1.33	1.33	1.22	0.82	1.29	0.96
Asset Turnover	1.64	1.64	1.69	1.87	1.80	1.95
Inventory Turnover	3.85	3.85	4.07	4.47	4.26	4.77
Quick Ratio	0.55	0.55	0.66	0.80	0.42	0.78
Current Ratio	1.55	1.55	1.69	1.70	1.40	1.72
Return on Equity (ROE)	32.51%	32.51%	37.93%	46.16%	44.13%	43.96%
Return on Assets (ROA)	9.44%	9.44%	11.64%	13.54%	12.65%	13.64%
Return on Capital (ROIC)	14.05%	14.05%	17.04%	19.61%	18.04%	19.12%
Return on Capital Employed (ROCE)	20.90%	20.90%	25.70%	29.10%	30.20%	29.70%
Earnings Yield	552.83%	5.37%	5.01%	4.08%	-	-
FCF Yield	775.85%	7.53%	5.40%	6.52%	-	-
Dividend Yield	481.61%	4.80%	4.29%	3.51%	-	-
Payout Ratio	8711.82%	87.12%	80.10%	33.83%	155.07%	63.01%
Buyback Yield / Dilution	-	-	-	-	-	-2500.00%
Total Shareholder Return	481.61%	4.80%	4.29%	3.51%	-	-2500.00%

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.